SlideShare uma empresa Scribd logo
1 de 11
Baixar para ler offline
© COPYRIGHT   COPENHAGEN CAPACITY / INVEST IN SKÅNE
02                                 MEDICON VALLEY / 2011




WELCOME TO
MEDICON VALLEY
SCANDINAVIA’S LIFE SCIENCE CENTRE




Looking for investment and business opportunities? Look
no further than Medicon Valley. Spanning eastern Den-
mark and the southern part of Sweden, Medicon Valley is
home to one of Europe’s strongest life science clusters.

With industry, academics, researchers, students and
clinicians working in close proximity, Medicon Valley                             Steven Burrill
                                                                                  CEO, Burrill & Company
has it all: a healthy pipeline of pharma, biotech and
medtech products and an abundance of exciting op-
                                                           “Medicon Valley is a region of the future
portunities for business and investment.
                                                           with tremendous opportunities. It offers
                                                           cutting-edge science, a powerful base of ex-
Medicon Valley can be accessed easily via Scandi-          perienced global players, institutional will, a
navia’s most important airport, CPH, which has the         large entrepreneurial base and commonali-
most inter-continental, European, Scandinavian and         ties which draw the industry together.”
Baltic flights of all the Scandinavian airports.
04                               MEDICON VALLEY / 2011




THE PLACE TO DEVELOP
YOUR BUSINESS




One of Europe’s top three pharma, biotech and medtech    FINANCE YOUR GROwTH IN MEDICON VALLEY
                                                         The majority of biotech companies in Medicon Valley emerged in the
clusters, Medicon Valley offers a healthy business
                                                         mid-1990s. Since then, most of them have succeeded in getting their
environment with opportunities for extensive collabo-
                                                         compounds into clinical development (see graph on next page),
ration and synergies between life science companies,     giving Medicon Valley one of the strongest biotech pipelines in Europe.
academic research centres and clinicians.
                                                         With more than a dozen active venture capitalists (VCs) specialising
                                                         in life science in the region, venture capital financing is extremely
                                                         stable. Typically, a Nordic VC will act as a lead investor in Medicon Valley
                                                         and syndicate investments with international or other Nordic VCs.

                                                         As the region’s overall clinical pipeline matures, international in-
                                                         vestors will play a key role. Thanks to a high concentration of bio-
                                                         tech companies with lead candidates in the late stages of clinical
                                                         development, Medicon Valley offers attractive business opportunities
                                                         for pharmaceutical companies and financial investors. Invest in
                                                         Skåne and Copenhagen Capacity have a long track record of helping
                                                         investors select companies and business opportunities that meet
                                                         their strategic goals – and we can do the same for you.



                                                         STRATEGIC ALLIANCE
                                                         When it comes to tapping into the business opportunities in
                                                         Medicon Valley, your company has many options. One is to establish
                                                         a strategic alliance with one of the 350 biotech and medtech
                                                         companies.
MEDICON VALLEY / 2011                                             05




                                                                           With close ties to local companies in Medicon Valley, Copen-
                                                                           hagen Capacity and Invest in Skåne are perfectly positioned
                                                                           to help you identify potential business partners. Every year,
                                                                           we help many international companies secure win-win
                                                                           agreements with companies in Medicon Valley. Read more at
                                                                           www.mediconvalley.com

                                                                           To see the latest opportunities at Medicon Valley as they
                                                                           arise, sign up for our monthly newsletter. Simply go to
                                                                           www.mediconvalley.com/subscribe



AN IMPRESSIVE PIPELINE
IN jUST TEN YEARS, MEDICON VALLEY HAS BECOME AN ESTABLISHED LIFE SCIENCE CLUSTER WITH A DIVERSE PIPELINE OF PROMISING LEAD CANDIDATES.


NUMBER OF PRODUCT CANDIDATES
PHASE 1                  PHASE 2               PHASE 3




UNITED KINGDOM
     GERMANY
     DENMARK
        FRANCE
 SWITZERLAND
       SWEDEN
         ISRAEL
            ITALY
 NETHERLANDS
       NORWAY
           SPAIN
       IRELAND
       BELGIUM
       AUSTRIA
       FINLAND

                     0                                50             100               150                        200                        250


SOURCE: Ernst & Young / Beyond borders 2011 (figures are for 2010)

                                                                           MINIMISE YOUR ADMINISTRATIVE COSTS
                                                                           Medicon Valley is a business-friendly region. Corporate tax
                                                                           rates are low in comparison with other mature economies in
                                                                           (western) Europe, moreover efficient government procedures
                                                                           enable your company to reduce administrative costs. This
                                                                           means you can allocate more resources to your business. In
                                                                           Medicon Valley, public authorities work with companies.




                                                                                                   Anna williamson
                                                                                                   Senior Manager,
                                                                                                   Business Development, Genentech



                                                                           The Medicon Valley has a well-established life sciences community
                                                                           with recognized strengths in drug discovery, development, diagnostics
                                                                           and medical devices. Genentech has a number of collaborations
                                                                           with top companies in the area and we continue to regard it as a
                                                                           high-potential region for sourcing business opportunities.
Medicon Valley Brochure
© COPYRIGHT   COPENHAGEN CAPACITY / INVEST IN SKÅNE
08                                        MEDICON VALLEY / 2011




HIGHLY EDUCATED
WORKFORCE




Your company’s most valuable asset is your staff.                     MANAGEMENT EXPERTISE
                                                                      In the last decade, more than a hundred biotech start-ups have
In Medicon Valley, you have immediate access to
                                                                      settled in Medicon Valley. Now mature, many of them are in late-
talented people who can become the world-class
                                                                      stage clinical development and preparing to partner or launch their
workforce you need to grow your business.                             lead candidates. After initial rounds of funding by venture capi-
                                                                      talists, some Medicon Valley companies have listed on the Nordic
                                                                      OMX or other stock exchanges. This shows the commitment and
                                                                      determination of local biotech executives who have what it takes
                                                                      to transform innovative start-ups into successful companies.



                                                                      ACADEMIC RESOURCES
RESEARCHERS AND LIFE SCIENCE SPECIALISTS                              Scandinavian countries are very focused on education. As a per-
About 44,000 people are employed in the private life science sector   centage of GDP, public spending on education is one of the high-
in Medicon Valley, and many of them work in R&D. The cluster is       est in the world (according to IMD, World Competitiveness Year
home to internationally renowned pharma, biotech, diagnostics and     book, 2010).
medtech companies, such as ArjoHuntleigh, Gambro, Novo Nordisk,
H. Lundbeck, Leo Pharma, DAKO, Coloplast and Ambu.                    Not surprisingly, Medicon Valley is home to some prestigious uni-
                                                                      versities, such as The Danish Technical University, Copenhagen
Medicon Valley plays host to 350 biotechnology and medtech com-       University and Lund University – all internationally recognised
panies – and offers all the skills and expertise you need to carry    for their advanced research facilities and outstanding achieve-
out demanding life science R&D. More than 50 companies can offer      ments. Medicon Valley’s 11 universities guarantee a steady sup-
you support in the form of preclinical or clinical development,       ply of highly qualified young people. And many of them will
IP consulting, and contract manufacturing.                            graduate with a degree directly relevant to life science.
MEDICON VALLEY / 2011                                         09




                        David H Solomon
                        President, Chief Executive Officer,
                        Zealand Pharma



“In order for a biopharmaceutical company like Zealand Pharma
to continue its success and to create value, it is of utmost im-
portance to have access to a pool of highly skilled and talented
scientists as well as senior managers with relevant business ex-
perience and an insightful understanding of the sector. All this
we find in the well-established and thriving environment of the
Medicon Valley region.”
10                              MEDICON VALLEY / 2011




A PERFECT WORK/
LIFE BALANCE




In Medicon Valley, combining work and family life       AN ATTRACTIVE PLACE TO LIVE
is easy – and highly appealing to expatriates.          Free schools, free healthcare, easy access to childcare, a safe,
                                                        healthy environment with a low crime rate and good leisure facili-
Companies offer flexible working hours so you can
                                                        ties – these are just some of the benefits of living and working in
balance a successful career with a rich, fulfilling     Medicon Valley.
family life.
                                                        With a rich heritage and modern facilities, the region’s principal
                                                        cities, Copenhagen and Malmö, offer unique cultural experiences
                                                        and plenty of opportunities for outdoor activities. What’s more,
                                                        forests and beaches are never more than half an hour’s drive away.

                                                        International, trendsetting magazine Monocle recently declared
                                                        Copenhagen the world’s second most attractive city to live in.
                                                        Monocle’s 2010 survey, which assessed 40 major cities on criteria
                                                        such as public transport, education, ease of doing business and
                                                        hours of sunshine, commended Copenhagen for its compact
                                                        town planning, good regional transport network and clean, safe
                                                        environment.
Medicon Valley Brochure
info@mediconvalley.com / www.mediconvalley.com




                     NøRREGADE 7B
                     1165 COPENHAGEN K
                     DENMARK

                     +45 33 22 02 22
                     info@copcap.com
                     www.copcap.com/lifescience




                     DOCKPLATSEN 26
                     205 25 MALMö
                     SWEDEN

                     +46 40 675 34 65
                     lifescience.invest@skane.com
                     invest.skane.com




                     LIFE SCIENCE SkåNE IS
                     PART-FINANCED BY THE EU




                           Investing in your future

Mais conteúdo relacionado

Semelhante a Medicon Valley Brochure

Adam Cary Portfolio 2015
Adam Cary Portfolio 2015Adam Cary Portfolio 2015
Adam Cary Portfolio 2015Adam Cary
 
Medilink Midlands Annual Report 2021
Medilink Midlands Annual Report 2021Medilink Midlands Annual Report 2021
Medilink Midlands Annual Report 2021Medilink Midlands
 
Medilink Midlands Annual Report 2022
Medilink Midlands Annual Report 2022Medilink Midlands Annual Report 2022
Medilink Midlands Annual Report 2022Medilink Midlands
 
Keynote Health Tech Event Eindhoven - Open Innovation Health Tech Opportuntie...
Keynote Health Tech Event Eindhoven - Open Innovation Health Tech Opportuntie...Keynote Health Tech Event Eindhoven - Open Innovation Health Tech Opportuntie...
Keynote Health Tech Event Eindhoven - Open Innovation Health Tech Opportuntie...BenHeublKeynotes
 
Blueprint for change concept climate bangladesh (bysted june 21)
Blueprint for change    concept climate  bangladesh (bysted june 21)Blueprint for change    concept climate  bangladesh (bysted june 21)
Blueprint for change concept climate bangladesh (bysted june 21)Bysted
 
Qualcomm life a vc's view of the m health opportunity
Qualcomm life a vc's view of the m health opportunityQualcomm life a vc's view of the m health opportunity
Qualcomm life a vc's view of the m health opportunity3GDR
 
Qualcomm Life Mobile Healthcare Industry Summit 2012 Don Jones
Qualcomm Life Mobile Healthcare Industry Summit 2012 Don JonesQualcomm Life Mobile Healthcare Industry Summit 2012 Don Jones
Qualcomm Life Mobile Healthcare Industry Summit 2012 Don Jones3GDR
 
St. Louis Arch Angels 2011 Annual Report
St. Louis Arch Angels 2011 Annual ReportSt. Louis Arch Angels 2011 Annual Report
St. Louis Arch Angels 2011 Annual Reportautomationkit
 
Communications Audit
Communications AuditCommunications Audit
Communications AuditKari Saunders
 
Koppar Entrepreneurial Challenges Opportunities Doordarshan 090306
Koppar Entrepreneurial Challenges  Opportunities  Doordarshan 090306Koppar Entrepreneurial Challenges  Opportunities  Doordarshan 090306
Koppar Entrepreneurial Challenges Opportunities Doordarshan 090306guest497a4b
 
MWV_AR_2005_Book1
MWV_AR_2005_Book1MWV_AR_2005_Book1
MWV_AR_2005_Book1finance33
 
E vresearch book20.01.13
E vresearch book20.01.13E vresearch book20.01.13
E vresearch book20.01.13Ged Mirfin
 
The Future of Wealth Management
The Future of Wealth ManagementThe Future of Wealth Management
The Future of Wealth ManagementClientific
 
Analysis Of The Union Of Medtronic And Covidien
Analysis Of The Union Of Medtronic And CovidienAnalysis Of The Union Of Medtronic And Covidien
Analysis Of The Union Of Medtronic And CovidienLisa Williams
 
thermo fisher 2005
thermo fisher 2005thermo fisher 2005
thermo fisher 2005finance40
 
thermo fisher 2005
thermo fisher 2005thermo fisher 2005
thermo fisher 2005finance40
 
10 Most Trusted Healthcare Consulting Companies 2022.pdf
10 Most Trusted Healthcare Consulting Companies 2022.pdf10 Most Trusted Healthcare Consulting Companies 2022.pdf
10 Most Trusted Healthcare Consulting Companies 2022.pdfinsightscare
 

Semelhante a Medicon Valley Brochure (20)

Adam Cary Portfolio 2015
Adam Cary Portfolio 2015Adam Cary Portfolio 2015
Adam Cary Portfolio 2015
 
Medilink Midlands Annual Report 2021
Medilink Midlands Annual Report 2021Medilink Midlands Annual Report 2021
Medilink Midlands Annual Report 2021
 
Medilink Midlands Annual Report 2022
Medilink Midlands Annual Report 2022Medilink Midlands Annual Report 2022
Medilink Midlands Annual Report 2022
 
Keynote Health Tech Event Eindhoven - Open Innovation Health Tech Opportuntie...
Keynote Health Tech Event Eindhoven - Open Innovation Health Tech Opportuntie...Keynote Health Tech Event Eindhoven - Open Innovation Health Tech Opportuntie...
Keynote Health Tech Event Eindhoven - Open Innovation Health Tech Opportuntie...
 
Blueprint for change concept climate bangladesh (bysted june 21)
Blueprint for change    concept climate  bangladesh (bysted june 21)Blueprint for change    concept climate  bangladesh (bysted june 21)
Blueprint for change concept climate bangladesh (bysted june 21)
 
Qualcomm life a vc's view of the m health opportunity
Qualcomm life a vc's view of the m health opportunityQualcomm life a vc's view of the m health opportunity
Qualcomm life a vc's view of the m health opportunity
 
Qualcomm Life Mobile Healthcare Industry Summit 2012 Don Jones
Qualcomm Life Mobile Healthcare Industry Summit 2012 Don JonesQualcomm Life Mobile Healthcare Industry Summit 2012 Don Jones
Qualcomm Life Mobile Healthcare Industry Summit 2012 Don Jones
 
St. Louis Arch Angels 2011 Annual Report
St. Louis Arch Angels 2011 Annual ReportSt. Louis Arch Angels 2011 Annual Report
St. Louis Arch Angels 2011 Annual Report
 
Communications Audit
Communications AuditCommunications Audit
Communications Audit
 
Koppar Entrepreneurial Challenges Opportunities Doordarshan 090306
Koppar Entrepreneurial Challenges  Opportunities  Doordarshan 090306Koppar Entrepreneurial Challenges  Opportunities  Doordarshan 090306
Koppar Entrepreneurial Challenges Opportunities Doordarshan 090306
 
CIT AR 05
CIT AR 05CIT AR 05
CIT AR 05
 
CIT AR 05
CIT AR 05CIT AR 05
CIT AR 05
 
MWV_AR_2005_Book1
MWV_AR_2005_Book1MWV_AR_2005_Book1
MWV_AR_2005_Book1
 
E vresearch book20.01.13
E vresearch book20.01.13E vresearch book20.01.13
E vresearch book20.01.13
 
The Future of Wealth Management
The Future of Wealth ManagementThe Future of Wealth Management
The Future of Wealth Management
 
Analysis Of The Union Of Medtronic And Covidien
Analysis Of The Union Of Medtronic And CovidienAnalysis Of The Union Of Medtronic And Covidien
Analysis Of The Union Of Medtronic And Covidien
 
MNC ACCENTURE PPT
MNC ACCENTURE PPTMNC ACCENTURE PPT
MNC ACCENTURE PPT
 
thermo fisher 2005
thermo fisher 2005thermo fisher 2005
thermo fisher 2005
 
thermo fisher 2005
thermo fisher 2005thermo fisher 2005
thermo fisher 2005
 
10 Most Trusted Healthcare Consulting Companies 2022.pdf
10 Most Trusted Healthcare Consulting Companies 2022.pdf10 Most Trusted Healthcare Consulting Companies 2022.pdf
10 Most Trusted Healthcare Consulting Companies 2022.pdf
 

Mais de EuroBioForum

EuroBioForum2014_speaker_Metspalu
EuroBioForum2014_speaker_MetspaluEuroBioForum2014_speaker_Metspalu
EuroBioForum2014_speaker_MetspaluEuroBioForum
 
EuroBioForum2014_speaker_director_Spek
EuroBioForum2014_speaker_director_SpekEuroBioForum2014_speaker_director_Spek
EuroBioForum2014_speaker_director_SpekEuroBioForum
 
EuroBioForum2014_speaker_Balling
EuroBioForum2014_speaker_BallingEuroBioForum2014_speaker_Balling
EuroBioForum2014_speaker_BallingEuroBioForum
 
EuroBioForum2014_sepaker_Palotie
EuroBioForum2014_sepaker_PalotieEuroBioForum2014_sepaker_Palotie
EuroBioForum2014_sepaker_PalotieEuroBioForum
 
EuroBioForum2014_speaker_Manolio
EuroBioForum2014_speaker_ManolioEuroBioForum2014_speaker_Manolio
EuroBioForum2014_speaker_ManolioEuroBioForum
 
EuroBioForum2014_speakers_Grinsven_Schoenmaker
EuroBioForum2014_speakers_Grinsven_SchoenmakerEuroBioForum2014_speakers_Grinsven_Schoenmaker
EuroBioForum2014_speakers_Grinsven_SchoenmakerEuroBioForum
 
EuroBioForum2014_speaker_Adami
EuroBioForum2014_speaker_AdamiEuroBioForum2014_speaker_Adami
EuroBioForum2014_speaker_AdamiEuroBioForum
 
EuroBioForum2014_speaker_Love
EuroBioForum2014_speaker_LoveEuroBioForum2014_speaker_Love
EuroBioForum2014_speaker_LoveEuroBioForum
 
EuroBioForum2014_speaker_bilbao
EuroBioForum2014_speaker_bilbaoEuroBioForum2014_speaker_bilbao
EuroBioForum2014_speaker_bilbaoEuroBioForum
 
EuroBioForum2014_speaker_simons
EuroBioForum2014_speaker_simonsEuroBioForum2014_speaker_simons
EuroBioForum2014_speaker_simonsEuroBioForum
 
Unlock Your Global Business Potential
Unlock Your Global Business PotentialUnlock Your Global Business Potential
Unlock Your Global Business PotentialEuroBioForum
 
EuroBioForum 2013 - Day 1 | Wolfgang Eberle
 EuroBioForum 2013 - Day 1 | Wolfgang Eberle EuroBioForum 2013 - Day 1 | Wolfgang Eberle
EuroBioForum 2013 - Day 1 | Wolfgang EberleEuroBioForum
 
EuroBioForum 2013 - Day 2 | Rachael Ritchie
EuroBioForum 2013 - Day 2 | Rachael RitchieEuroBioForum 2013 - Day 2 | Rachael Ritchie
EuroBioForum 2013 - Day 2 | Rachael RitchieEuroBioForum
 
The heart of life sciences full report
The heart of life sciences full reportThe heart of life sciences full report
The heart of life sciences full reportEuroBioForum
 
EuroBioForum 2013 - Day 2 | Jami Taylor
 EuroBioForum 2013 - Day 2 | Jami Taylor EuroBioForum 2013 - Day 2 | Jami Taylor
EuroBioForum 2013 - Day 2 | Jami TaylorEuroBioForum
 
EuroBioForum 2013 - Day 2 | Pelagiya Dragomirova
EuroBioForum 2013 - Day 2 | Pelagiya DragomirovaEuroBioForum 2013 - Day 2 | Pelagiya Dragomirova
EuroBioForum 2013 - Day 2 | Pelagiya DragomirovaEuroBioForum
 
EuroBioForum 2013 - Day 2 | Frank Molina
 EuroBioForum 2013 - Day 2 | Frank Molina EuroBioForum 2013 - Day 2 | Frank Molina
EuroBioForum 2013 - Day 2 | Frank MolinaEuroBioForum
 
EuroBioForum 2013 - Day 2 | Mark Poznansky
 EuroBioForum 2013 - Day 2 | Mark Poznansky EuroBioForum 2013 - Day 2 | Mark Poznansky
EuroBioForum 2013 - Day 2 | Mark PoznanskyEuroBioForum
 
EuroBioForum 2013 - Day 2 | Marc Lapage
EuroBioForum 2013 - Day 2 | Marc LapageEuroBioForum 2013 - Day 2 | Marc Lapage
EuroBioForum 2013 - Day 2 | Marc LapageEuroBioForum
 
EuroBioForum 2013 - Day 2 | Menno Kok
 EuroBioForum 2013 - Day 2 | Menno Kok EuroBioForum 2013 - Day 2 | Menno Kok
EuroBioForum 2013 - Day 2 | Menno KokEuroBioForum
 

Mais de EuroBioForum (20)

EuroBioForum2014_speaker_Metspalu
EuroBioForum2014_speaker_MetspaluEuroBioForum2014_speaker_Metspalu
EuroBioForum2014_speaker_Metspalu
 
EuroBioForum2014_speaker_director_Spek
EuroBioForum2014_speaker_director_SpekEuroBioForum2014_speaker_director_Spek
EuroBioForum2014_speaker_director_Spek
 
EuroBioForum2014_speaker_Balling
EuroBioForum2014_speaker_BallingEuroBioForum2014_speaker_Balling
EuroBioForum2014_speaker_Balling
 
EuroBioForum2014_sepaker_Palotie
EuroBioForum2014_sepaker_PalotieEuroBioForum2014_sepaker_Palotie
EuroBioForum2014_sepaker_Palotie
 
EuroBioForum2014_speaker_Manolio
EuroBioForum2014_speaker_ManolioEuroBioForum2014_speaker_Manolio
EuroBioForum2014_speaker_Manolio
 
EuroBioForum2014_speakers_Grinsven_Schoenmaker
EuroBioForum2014_speakers_Grinsven_SchoenmakerEuroBioForum2014_speakers_Grinsven_Schoenmaker
EuroBioForum2014_speakers_Grinsven_Schoenmaker
 
EuroBioForum2014_speaker_Adami
EuroBioForum2014_speaker_AdamiEuroBioForum2014_speaker_Adami
EuroBioForum2014_speaker_Adami
 
EuroBioForum2014_speaker_Love
EuroBioForum2014_speaker_LoveEuroBioForum2014_speaker_Love
EuroBioForum2014_speaker_Love
 
EuroBioForum2014_speaker_bilbao
EuroBioForum2014_speaker_bilbaoEuroBioForum2014_speaker_bilbao
EuroBioForum2014_speaker_bilbao
 
EuroBioForum2014_speaker_simons
EuroBioForum2014_speaker_simonsEuroBioForum2014_speaker_simons
EuroBioForum2014_speaker_simons
 
Unlock Your Global Business Potential
Unlock Your Global Business PotentialUnlock Your Global Business Potential
Unlock Your Global Business Potential
 
EuroBioForum 2013 - Day 1 | Wolfgang Eberle
 EuroBioForum 2013 - Day 1 | Wolfgang Eberle EuroBioForum 2013 - Day 1 | Wolfgang Eberle
EuroBioForum 2013 - Day 1 | Wolfgang Eberle
 
EuroBioForum 2013 - Day 2 | Rachael Ritchie
EuroBioForum 2013 - Day 2 | Rachael RitchieEuroBioForum 2013 - Day 2 | Rachael Ritchie
EuroBioForum 2013 - Day 2 | Rachael Ritchie
 
The heart of life sciences full report
The heart of life sciences full reportThe heart of life sciences full report
The heart of life sciences full report
 
EuroBioForum 2013 - Day 2 | Jami Taylor
 EuroBioForum 2013 - Day 2 | Jami Taylor EuroBioForum 2013 - Day 2 | Jami Taylor
EuroBioForum 2013 - Day 2 | Jami Taylor
 
EuroBioForum 2013 - Day 2 | Pelagiya Dragomirova
EuroBioForum 2013 - Day 2 | Pelagiya DragomirovaEuroBioForum 2013 - Day 2 | Pelagiya Dragomirova
EuroBioForum 2013 - Day 2 | Pelagiya Dragomirova
 
EuroBioForum 2013 - Day 2 | Frank Molina
 EuroBioForum 2013 - Day 2 | Frank Molina EuroBioForum 2013 - Day 2 | Frank Molina
EuroBioForum 2013 - Day 2 | Frank Molina
 
EuroBioForum 2013 - Day 2 | Mark Poznansky
 EuroBioForum 2013 - Day 2 | Mark Poznansky EuroBioForum 2013 - Day 2 | Mark Poznansky
EuroBioForum 2013 - Day 2 | Mark Poznansky
 
EuroBioForum 2013 - Day 2 | Marc Lapage
EuroBioForum 2013 - Day 2 | Marc LapageEuroBioForum 2013 - Day 2 | Marc Lapage
EuroBioForum 2013 - Day 2 | Marc Lapage
 
EuroBioForum 2013 - Day 2 | Menno Kok
 EuroBioForum 2013 - Day 2 | Menno Kok EuroBioForum 2013 - Day 2 | Menno Kok
EuroBioForum 2013 - Day 2 | Menno Kok
 

Último

MARKET FAILURE SITUATION IN THE ECONOMY.
MARKET FAILURE SITUATION IN THE ECONOMY.MARKET FAILURE SITUATION IN THE ECONOMY.
MARKET FAILURE SITUATION IN THE ECONOMY.Arifa Saeed
 
20240314 Calibre March 2024 Investor Presentation (FINAL).pdf
20240314 Calibre March 2024 Investor Presentation (FINAL).pdf20240314 Calibre March 2024 Investor Presentation (FINAL).pdf
20240314 Calibre March 2024 Investor Presentation (FINAL).pdfAdnet Communications
 
ACCOUNTING FOR BUSINESS.II BRANCH ACCOUNTS NOTES
ACCOUNTING FOR BUSINESS.II BRANCH ACCOUNTS NOTESACCOUNTING FOR BUSINESS.II BRANCH ACCOUNTS NOTES
ACCOUNTING FOR BUSINESS.II BRANCH ACCOUNTS NOTESKumarJayaraman3
 
ACCOUNTING FOR BUSINESS.II DEPARTMENTAL ACCOUNTS.
ACCOUNTING FOR BUSINESS.II DEPARTMENTAL ACCOUNTS.ACCOUNTING FOR BUSINESS.II DEPARTMENTAL ACCOUNTS.
ACCOUNTING FOR BUSINESS.II DEPARTMENTAL ACCOUNTS.KumarJayaraman3
 
Work and Pensions report into UK corporate DB funding
Work and Pensions report into UK corporate DB fundingWork and Pensions report into UK corporate DB funding
Work and Pensions report into UK corporate DB fundingHenry Tapper
 
Contracts with Interdependent Preferences
Contracts with Interdependent PreferencesContracts with Interdependent Preferences
Contracts with Interdependent PreferencesGRAPE
 
The CBR Covered Bond Investor Roundtable 2024
The CBR Covered Bond Investor Roundtable 2024The CBR Covered Bond Investor Roundtable 2024
The CBR Covered Bond Investor Roundtable 2024Neil Day
 
Stock Market Brief Deck for March 26.pdf
Stock Market Brief Deck for March 26.pdfStock Market Brief Deck for March 26.pdf
Stock Market Brief Deck for March 26.pdfMichael Silva
 
Zakat and it’s Social Benefits - THE FORGOTTEN PILLAR OF ISLAM
Zakat and it’s Social Benefits - THE FORGOTTEN PILLAR OF ISLAMZakat and it’s Social Benefits - THE FORGOTTEN PILLAR OF ISLAM
Zakat and it’s Social Benefits - THE FORGOTTEN PILLAR OF ISLAMFaisal834049
 
RWA Report 2024: Rise of Real-World Assets in Crypto | CoinGecko
RWA Report 2024: Rise of Real-World Assets in Crypto | CoinGeckoRWA Report 2024: Rise of Real-World Assets in Crypto | CoinGecko
RWA Report 2024: Rise of Real-World Assets in Crypto | CoinGeckoCoinGecko
 
Solution manual for Intermediate Accounting, 11th Edition by David Spiceland...
Solution manual for  Intermediate Accounting, 11th Edition by David Spiceland...Solution manual for  Intermediate Accounting, 11th Edition by David Spiceland...
Solution manual for Intermediate Accounting, 11th Edition by David Spiceland...mwangimwangi222
 
The Power Laws of Bitcoin: How can an S-curve be a power law?
The Power Laws of Bitcoin: How can an S-curve be a power law?The Power Laws of Bitcoin: How can an S-curve be a power law?
The Power Laws of Bitcoin: How can an S-curve be a power law?Stephen Perrenod
 
LIC PRIVATISATION its a bane or boon.pptx
LIC PRIVATISATION its a bane or boon.pptxLIC PRIVATISATION its a bane or boon.pptx
LIC PRIVATISATION its a bane or boon.pptxsonamyadav7097
 
CLMV-Outlook-March-2024-ENG-20240327.pdf
CLMV-Outlook-March-2024-ENG-20240327.pdfCLMV-Outlook-March-2024-ENG-20240327.pdf
CLMV-Outlook-March-2024-ENG-20240327.pdfSCBEICSCB
 
Sarlat Advisory - Corporate Brochure - 2024
Sarlat Advisory - Corporate Brochure - 2024Sarlat Advisory - Corporate Brochure - 2024
Sarlat Advisory - Corporate Brochure - 2024Guillaume Ⓥ Sarlat
 
ACADEMIC BANK OF CREDIT: A WORLDWIDE VIEWPOINT
ACADEMIC BANK OF CREDIT: A WORLDWIDE VIEWPOINTACADEMIC BANK OF CREDIT: A WORLDWIDE VIEWPOINT
ACADEMIC BANK OF CREDIT: A WORLDWIDE VIEWPOINTindexPub
 
Hungarys economy made by Robert Miklos
Hungarys economy   made by Robert MiklosHungarys economy   made by Robert Miklos
Hungarys economy made by Robert Miklosbeduinpower135
 
Lundin Gold March 2024 Corporate Presentation - PDAC v1.pdf
Lundin Gold March 2024 Corporate Presentation - PDAC v1.pdfLundin Gold March 2024 Corporate Presentation - PDAC v1.pdf
Lundin Gold March 2024 Corporate Presentation - PDAC v1.pdfAdnet Communications
 
India Economic Survey Complete for the year of 2022 to 2023
India Economic Survey Complete for the year of 2022 to 2023India Economic Survey Complete for the year of 2022 to 2023
India Economic Survey Complete for the year of 2022 to 2023SkillCircle
 

Último (20)

MARKET FAILURE SITUATION IN THE ECONOMY.
MARKET FAILURE SITUATION IN THE ECONOMY.MARKET FAILURE SITUATION IN THE ECONOMY.
MARKET FAILURE SITUATION IN THE ECONOMY.
 
20240314 Calibre March 2024 Investor Presentation (FINAL).pdf
20240314 Calibre March 2024 Investor Presentation (FINAL).pdf20240314 Calibre March 2024 Investor Presentation (FINAL).pdf
20240314 Calibre March 2024 Investor Presentation (FINAL).pdf
 
ACCOUNTING FOR BUSINESS.II BRANCH ACCOUNTS NOTES
ACCOUNTING FOR BUSINESS.II BRANCH ACCOUNTS NOTESACCOUNTING FOR BUSINESS.II BRANCH ACCOUNTS NOTES
ACCOUNTING FOR BUSINESS.II BRANCH ACCOUNTS NOTES
 
ACCOUNTING FOR BUSINESS.II DEPARTMENTAL ACCOUNTS.
ACCOUNTING FOR BUSINESS.II DEPARTMENTAL ACCOUNTS.ACCOUNTING FOR BUSINESS.II DEPARTMENTAL ACCOUNTS.
ACCOUNTING FOR BUSINESS.II DEPARTMENTAL ACCOUNTS.
 
Work and Pensions report into UK corporate DB funding
Work and Pensions report into UK corporate DB fundingWork and Pensions report into UK corporate DB funding
Work and Pensions report into UK corporate DB funding
 
Contracts with Interdependent Preferences
Contracts with Interdependent PreferencesContracts with Interdependent Preferences
Contracts with Interdependent Preferences
 
The CBR Covered Bond Investor Roundtable 2024
The CBR Covered Bond Investor Roundtable 2024The CBR Covered Bond Investor Roundtable 2024
The CBR Covered Bond Investor Roundtable 2024
 
Stock Market Brief Deck for March 26.pdf
Stock Market Brief Deck for March 26.pdfStock Market Brief Deck for March 26.pdf
Stock Market Brief Deck for March 26.pdf
 
Zakat and it’s Social Benefits - THE FORGOTTEN PILLAR OF ISLAM
Zakat and it’s Social Benefits - THE FORGOTTEN PILLAR OF ISLAMZakat and it’s Social Benefits - THE FORGOTTEN PILLAR OF ISLAM
Zakat and it’s Social Benefits - THE FORGOTTEN PILLAR OF ISLAM
 
RWA Report 2024: Rise of Real-World Assets in Crypto | CoinGecko
RWA Report 2024: Rise of Real-World Assets in Crypto | CoinGeckoRWA Report 2024: Rise of Real-World Assets in Crypto | CoinGecko
RWA Report 2024: Rise of Real-World Assets in Crypto | CoinGecko
 
Solution manual for Intermediate Accounting, 11th Edition by David Spiceland...
Solution manual for  Intermediate Accounting, 11th Edition by David Spiceland...Solution manual for  Intermediate Accounting, 11th Edition by David Spiceland...
Solution manual for Intermediate Accounting, 11th Edition by David Spiceland...
 
The Power Laws of Bitcoin: How can an S-curve be a power law?
The Power Laws of Bitcoin: How can an S-curve be a power law?The Power Laws of Bitcoin: How can an S-curve be a power law?
The Power Laws of Bitcoin: How can an S-curve be a power law?
 
LIC PRIVATISATION its a bane or boon.pptx
LIC PRIVATISATION its a bane or boon.pptxLIC PRIVATISATION its a bane or boon.pptx
LIC PRIVATISATION its a bane or boon.pptx
 
CLMV-Outlook-March-2024-ENG-20240327.pdf
CLMV-Outlook-March-2024-ENG-20240327.pdfCLMV-Outlook-March-2024-ENG-20240327.pdf
CLMV-Outlook-March-2024-ENG-20240327.pdf
 
Sarlat Advisory - Corporate Brochure - 2024
Sarlat Advisory - Corporate Brochure - 2024Sarlat Advisory - Corporate Brochure - 2024
Sarlat Advisory - Corporate Brochure - 2024
 
Digital Financial Services Taxation in Africa
Digital Financial Services Taxation in AfricaDigital Financial Services Taxation in Africa
Digital Financial Services Taxation in Africa
 
ACADEMIC BANK OF CREDIT: A WORLDWIDE VIEWPOINT
ACADEMIC BANK OF CREDIT: A WORLDWIDE VIEWPOINTACADEMIC BANK OF CREDIT: A WORLDWIDE VIEWPOINT
ACADEMIC BANK OF CREDIT: A WORLDWIDE VIEWPOINT
 
Hungarys economy made by Robert Miklos
Hungarys economy   made by Robert MiklosHungarys economy   made by Robert Miklos
Hungarys economy made by Robert Miklos
 
Lundin Gold March 2024 Corporate Presentation - PDAC v1.pdf
Lundin Gold March 2024 Corporate Presentation - PDAC v1.pdfLundin Gold March 2024 Corporate Presentation - PDAC v1.pdf
Lundin Gold March 2024 Corporate Presentation - PDAC v1.pdf
 
India Economic Survey Complete for the year of 2022 to 2023
India Economic Survey Complete for the year of 2022 to 2023India Economic Survey Complete for the year of 2022 to 2023
India Economic Survey Complete for the year of 2022 to 2023
 

Medicon Valley Brochure

  • 1. © COPYRIGHT COPENHAGEN CAPACITY / INVEST IN SKÅNE
  • 2. 02 MEDICON VALLEY / 2011 WELCOME TO MEDICON VALLEY SCANDINAVIA’S LIFE SCIENCE CENTRE Looking for investment and business opportunities? Look no further than Medicon Valley. Spanning eastern Den- mark and the southern part of Sweden, Medicon Valley is home to one of Europe’s strongest life science clusters. With industry, academics, researchers, students and clinicians working in close proximity, Medicon Valley Steven Burrill CEO, Burrill & Company has it all: a healthy pipeline of pharma, biotech and medtech products and an abundance of exciting op- “Medicon Valley is a region of the future portunities for business and investment. with tremendous opportunities. It offers cutting-edge science, a powerful base of ex- Medicon Valley can be accessed easily via Scandi- perienced global players, institutional will, a navia’s most important airport, CPH, which has the large entrepreneurial base and commonali- most inter-continental, European, Scandinavian and ties which draw the industry together.” Baltic flights of all the Scandinavian airports.
  • 3. 04 MEDICON VALLEY / 2011 THE PLACE TO DEVELOP YOUR BUSINESS One of Europe’s top three pharma, biotech and medtech FINANCE YOUR GROwTH IN MEDICON VALLEY The majority of biotech companies in Medicon Valley emerged in the clusters, Medicon Valley offers a healthy business mid-1990s. Since then, most of them have succeeded in getting their environment with opportunities for extensive collabo- compounds into clinical development (see graph on next page), ration and synergies between life science companies, giving Medicon Valley one of the strongest biotech pipelines in Europe. academic research centres and clinicians. With more than a dozen active venture capitalists (VCs) specialising in life science in the region, venture capital financing is extremely stable. Typically, a Nordic VC will act as a lead investor in Medicon Valley and syndicate investments with international or other Nordic VCs. As the region’s overall clinical pipeline matures, international in- vestors will play a key role. Thanks to a high concentration of bio- tech companies with lead candidates in the late stages of clinical development, Medicon Valley offers attractive business opportunities for pharmaceutical companies and financial investors. Invest in Skåne and Copenhagen Capacity have a long track record of helping investors select companies and business opportunities that meet their strategic goals – and we can do the same for you. STRATEGIC ALLIANCE When it comes to tapping into the business opportunities in Medicon Valley, your company has many options. One is to establish a strategic alliance with one of the 350 biotech and medtech companies.
  • 4. MEDICON VALLEY / 2011 05 With close ties to local companies in Medicon Valley, Copen- hagen Capacity and Invest in Skåne are perfectly positioned to help you identify potential business partners. Every year, we help many international companies secure win-win agreements with companies in Medicon Valley. Read more at www.mediconvalley.com To see the latest opportunities at Medicon Valley as they arise, sign up for our monthly newsletter. Simply go to www.mediconvalley.com/subscribe AN IMPRESSIVE PIPELINE IN jUST TEN YEARS, MEDICON VALLEY HAS BECOME AN ESTABLISHED LIFE SCIENCE CLUSTER WITH A DIVERSE PIPELINE OF PROMISING LEAD CANDIDATES. NUMBER OF PRODUCT CANDIDATES PHASE 1 PHASE 2 PHASE 3 UNITED KINGDOM GERMANY DENMARK FRANCE SWITZERLAND SWEDEN ISRAEL ITALY NETHERLANDS NORWAY SPAIN IRELAND BELGIUM AUSTRIA FINLAND 0 50 100 150 200 250 SOURCE: Ernst & Young / Beyond borders 2011 (figures are for 2010) MINIMISE YOUR ADMINISTRATIVE COSTS Medicon Valley is a business-friendly region. Corporate tax rates are low in comparison with other mature economies in (western) Europe, moreover efficient government procedures enable your company to reduce administrative costs. This means you can allocate more resources to your business. In Medicon Valley, public authorities work with companies. Anna williamson Senior Manager, Business Development, Genentech The Medicon Valley has a well-established life sciences community with recognized strengths in drug discovery, development, diagnostics and medical devices. Genentech has a number of collaborations with top companies in the area and we continue to regard it as a high-potential region for sourcing business opportunities.
  • 6. © COPYRIGHT COPENHAGEN CAPACITY / INVEST IN SKÅNE
  • 7. 08 MEDICON VALLEY / 2011 HIGHLY EDUCATED WORKFORCE Your company’s most valuable asset is your staff. MANAGEMENT EXPERTISE In the last decade, more than a hundred biotech start-ups have In Medicon Valley, you have immediate access to settled in Medicon Valley. Now mature, many of them are in late- talented people who can become the world-class stage clinical development and preparing to partner or launch their workforce you need to grow your business. lead candidates. After initial rounds of funding by venture capi- talists, some Medicon Valley companies have listed on the Nordic OMX or other stock exchanges. This shows the commitment and determination of local biotech executives who have what it takes to transform innovative start-ups into successful companies. ACADEMIC RESOURCES RESEARCHERS AND LIFE SCIENCE SPECIALISTS Scandinavian countries are very focused on education. As a per- About 44,000 people are employed in the private life science sector centage of GDP, public spending on education is one of the high- in Medicon Valley, and many of them work in R&D. The cluster is est in the world (according to IMD, World Competitiveness Year home to internationally renowned pharma, biotech, diagnostics and book, 2010). medtech companies, such as ArjoHuntleigh, Gambro, Novo Nordisk, H. Lundbeck, Leo Pharma, DAKO, Coloplast and Ambu. Not surprisingly, Medicon Valley is home to some prestigious uni- versities, such as The Danish Technical University, Copenhagen Medicon Valley plays host to 350 biotechnology and medtech com- University and Lund University – all internationally recognised panies – and offers all the skills and expertise you need to carry for their advanced research facilities and outstanding achieve- out demanding life science R&D. More than 50 companies can offer ments. Medicon Valley’s 11 universities guarantee a steady sup- you support in the form of preclinical or clinical development, ply of highly qualified young people. And many of them will IP consulting, and contract manufacturing. graduate with a degree directly relevant to life science.
  • 8. MEDICON VALLEY / 2011 09 David H Solomon President, Chief Executive Officer, Zealand Pharma “In order for a biopharmaceutical company like Zealand Pharma to continue its success and to create value, it is of utmost im- portance to have access to a pool of highly skilled and talented scientists as well as senior managers with relevant business ex- perience and an insightful understanding of the sector. All this we find in the well-established and thriving environment of the Medicon Valley region.”
  • 9. 10 MEDICON VALLEY / 2011 A PERFECT WORK/ LIFE BALANCE In Medicon Valley, combining work and family life AN ATTRACTIVE PLACE TO LIVE is easy – and highly appealing to expatriates. Free schools, free healthcare, easy access to childcare, a safe, healthy environment with a low crime rate and good leisure facili- Companies offer flexible working hours so you can ties – these are just some of the benefits of living and working in balance a successful career with a rich, fulfilling Medicon Valley. family life. With a rich heritage and modern facilities, the region’s principal cities, Copenhagen and Malmö, offer unique cultural experiences and plenty of opportunities for outdoor activities. What’s more, forests and beaches are never more than half an hour’s drive away. International, trendsetting magazine Monocle recently declared Copenhagen the world’s second most attractive city to live in. Monocle’s 2010 survey, which assessed 40 major cities on criteria such as public transport, education, ease of doing business and hours of sunshine, commended Copenhagen for its compact town planning, good regional transport network and clean, safe environment.
  • 11. info@mediconvalley.com / www.mediconvalley.com NøRREGADE 7B 1165 COPENHAGEN K DENMARK +45 33 22 02 22 info@copcap.com www.copcap.com/lifescience DOCKPLATSEN 26 205 25 MALMö SWEDEN +46 40 675 34 65 lifescience.invest@skane.com invest.skane.com LIFE SCIENCE SkåNE IS PART-FINANCED BY THE EU Investing in your future